These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 435770)

  • 21. Comparative cost of hyoscine injections.
    Bausewein C
    Palliat Med; 1995 Jul; 9(3):256. PubMed ID: 7582183
    [No Abstract]   [Full Text] [Related]  

  • 22. Edrophonium-hyoscine butylbromide mixture for reversal of neuromuscular blockade: heart rate changes in infants and children.
    Yamashita M; Tajima K
    Anaesthesia; 1988 Jul; 43(7):591-3. PubMed ID: 3414927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyoscine butylbromide mode of action on bowel motility: From pharmacology to clinical practice.
    Corsetti M; Forestier S; Jiménez M
    Neurogastroenterol Motil; 2023 Apr; 35(4):e14451. PubMed ID: 35972266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.
    Tytgat GN
    Drugs; 2007; 67(9):1343-57. PubMed ID: 17547475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the pharmacologic effect and clinical use of hyoscine-N-butylbromide (buscopan)].
    HEINKEL K
    Dtsch Z Verdau Stoffwechselkr; 1951 Jul; 11(4):180-95. PubMed ID: 14872696
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyoscine butylbromide to relieve utero-tubal obstruction at hysterosalpingography.
    Alper MM; Garner PR; Spence JE
    Br J Radiol; 1985 Sep; 58(693):915. PubMed ID: 3842296
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative study of two antispasmodic products: Buscopan and NO-Spa.
    Maitai CK; Njoroge DK; Munenge RW
    East Afr Med J; 1985 Jul; 62(7):480-5. PubMed ID: 4076027
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sonographic study of the effect of hyoscin-N-butylbromide on cholecystokinin stimulated gallbladder motility].
    Wagner T; Botzler R; Ritter U
    Z Gastroenterol; 1984 Jun; 22(6):305-10. PubMed ID: 6464523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyoscine-N-butylbromide by intravenous infusion.
    Butler HE; Moody HR
    Med J Aust; 1987 Sep; 147(6):315-6. PubMed ID: 3626960
    [No Abstract]   [Full Text] [Related]  

  • 30. Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.
    Ferrari A; Cavallero M; Spandre M; Gemme C; Rossini FP; Imbimbo BP
    Clin Ther; 1986; 8(3):320-8. PubMed ID: 3521859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angioneurotic oedema and urticaria induced by hyoscine butylbromide.
    Robinson AC; Teeling M
    Postgrad Med J; 1982 May; 58(679):316. PubMed ID: 7111123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edrophonium-hyoscine butylbromide mixture in neonates.
    Yamashita M; Tajima K
    Anaesthesia; 1989 Feb; 44(2):169. PubMed ID: 2929951
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants].
    GADEKE R
    Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of acute post-laparoscopy bowel hypermotility and treatment with hyoscine butylbromide.
    Bonnett TJ; Lashen H
    J Perioper Pract; 2009 Dec; 19(12):436-7. PubMed ID: 20225737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echocardiographic evaluation of vagolytic effects of hyoscine butylbromide in paediatric halothane anaesthesia.
    Yamashita M; Horigome H
    Agressologie; 1989 Sep; 30(8):489-91. PubMed ID: 2610296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of hyoscine butylbromide on the swallowing of capsules.
    Channer KS; Wolinski A; Kaye B; Virjee J
    Br J Clin Pharmacol; 1983 May; 15(5):560-3. PubMed ID: 6860531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of intravenous hyoscine-N-butylbromide during colonoscopy: a prospective, randomized, double-blind, placebo-controlled study.
    Dinc B; Gunduz UR; Bas B; Ay N; Koc U; Oner OZ; Gomceli I
    Acta Gastroenterol Belg; 2016; 79(2):179-85. PubMed ID: 27382934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response relationships of intravenous hyoscine butylbromide and atropine sulphate on heart rate in healthy volunteers.
    Grainger SL; Smith SE
    Br J Clin Pharmacol; 1983 Dec; 16(6):623-6. PubMed ID: 6661345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colonic distention at CT colonography: randomized evaluation of both IV hyoscine butylbromide and automated carbon dioxide insufflation.
    Nagata K; Fujiwara M; Shimamoto T; Iida N; Mogi T; Mitsushima T
    AJR Am J Roentgenol; 2015 Jan; 204(1):76-82. PubMed ID: 25539240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency department management of undifferentiated abdominal pain with hyoscine butylbromide and paracetamol: a randomised control trial.
    Remington-Hobbs J; Petts G; Harris T
    Emerg Med J; 2012 Dec; 29(12):989-94. PubMed ID: 22307926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.